Charles River Laboratories International Inc (CRL)
233.47
+3.58
(+1.56%)
USD |
NYSE |
May 03, 16:00
233.40
-0.06
(-0.03%)
Pre-Market: 20:00
Charles River Laboratories International Free Cash Flow: 365.37M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 365.37M |
| September 30, 2023 | 368.48M |
| June 30, 2023 | 289.37M |
| March 31, 2023 | 275.25M |
| December 31, 2022 | 294.91M |
| September 30, 2022 | 279.66M |
| June 30, 2022 | 338.46M |
| March 31, 2022 | 411.99M |
| December 31, 2021 | 532.03M |
| September 30, 2021 | 452.07M |
| June 30, 2021 | 484.00M |
| March 31, 2021 | 479.34M |
| December 31, 2020 | 380.02M |
| September 30, 2020 | 446.33M |
| June 30, 2020 | 415.90M |
| March 31, 2020 | 385.16M |
| December 31, 2019 | 340.42M |
| September 30, 2019 | 294.88M |
| June 30, 2019 | 269.00M |
| March 31, 2019 | 266.89M |
| December 31, 2018 | 301.09M |
| September 30, 2018 | 325.52M |
| June 30, 2018 | 268.19M |
| March 31, 2018 | 250.33M |
| December 31, 2017 | 235.64M |
| Date | Value |
|---|---|
| September 30, 2017 | 234.31M |
| June 30, 2017 | 258.91M |
| March 31, 2017 | 242.14M |
| December 31, 2016 | 261.61M |
| September 30, 2016 | 259.29M |
| June 30, 2016 | 274.72M |
| March 31, 2016 | 278.52M |
| December 31, 2015 | 241.70M |
| September 30, 2015 | 221.94M |
| June 30, 2015 | 202.00M |
| March 31, 2015 | 177.80M |
| December 31, 2014 | 194.13M |
| September 30, 2014 | 170.09M |
| June 30, 2014 | 170.46M |
| March 31, 2014 | 161.05M |
| December 31, 2013 | 167.98M |
| September 30, 2013 | 170.47M |
| June 30, 2013 | 163.14M |
| March 31, 2013 | 172.75M |
| December 31, 2012 | 160.37M |
| September 30, 2012 | 154.16M |
| June 30, 2012 | 143.64M |
| March 31, 2012 | 152.74M |
| December 31, 2011 | 156.14M |
| September 30, 2011 | 163.15M |
Free Cash Flow Range, Past 5 Years
269.00M
Minimum
Jun 2019
532.03M
Maximum
Dec 2021
373.82M
Average
368.48M
Median
Sep 2023
Free Cash Flow Benchmarks
| Cardinal Health Inc | 2.008B |
| Stryker Corp | 2.858B |
| DaVita Inc | 920.34M |
| IDEXX Laboratories Inc | 796.79M |
| Medpace Holdings Inc | 473.34M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 220.94M |
| Cash from Investing (Quarterly) | -238.37M |
| Cash from Financing (Quarterly) | 123.57M |
| Free Cash Flow Per Share (Quarterly) | 2.779 |
| Free Cash Flow to Equity (Quarterly) | 9.69M |
| Free Cash Flow to Firm (Quarterly) | 171.55M |
| Free Cash Flow Yield | 3.04% |